Daffohils Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 11-12-2024
- Paid Up Capital ₹ 1.04 M
as on 11-12-2024
- Company Age 25 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.96 Cr
as on 11-12-2024
- Revenue 255.17%
(FY 2022)
- Profit -79.56%
(FY 2022)
- Ebitda -118.34%
(FY 2022)
- Net Worth -19.11%
(FY 2022)
- Total Assets 8.85%
(FY 2022)
About Daffohils Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.04 M.
The company has closed loans amounting to ₹5.96 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Dinesh Parwanda and Reena Parwanda serve as directors at the Company.
- CIN/LLPIN
U24231UR1999PTC024849
- Company No.
024849
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Oct 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Daffohils Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Parwanda  | Director | 30-Jun-2023 | Current |
| Reena Parwanda | Director | 30-Jun-2023 | Current |
Financial Performance of Daffohils Pharma.
Daffohils Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 255.17% increase. The company also saw a substantial fall in profitability, with a 79.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Daffohils Pharma?
Unlock access to Daffohils Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Trinity Touch Private LimitedActive 54 years 6 monthsDinesh Parwanda and Reena Parwanda are mutual person
- Trinity Automation Private LimitedActive 16 years 5 months
Dinesh Parwanda and Reena Parwanda are mutual person
- Tridens Capital Private LimitedActive 39 years 3 months
Dinesh Parwanda and Reena Parwanda are mutual person
- Consolidated Developers Private LimitedActive 36 years 4 months
Dinesh Parwanda and Reena Parwanda are mutual person
- Residency Farms Pvt LtdActive 36 years 4 months
Dinesh Parwanda and Reena Parwanda are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 01 Oct 2010 | ₹3.24 Cr | Satisfied |
Bank Of Baroda Creation Date: 07 Sep 2006 | ₹2.09 Cr | Satisfied |
Punjab National Bank Creation Date: 30 Nov 2004 | ₹1.50 M | Satisfied |
How Many Employees Work at Daffohils Pharma?
Daffohils Pharma has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Daffohils Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daffohils Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
